Bortezomib-based Anthracycline-free Induction for Pediatric Relapsed ALL as a Bridge to Immunotherapy

MLA

Bella Beilorai, et al. “Bortezomib-Based Anthracycline-Free Induction for Pediatric Relapsed ALL as a Bridge to Immunotherapy.” Journal of Pediatric Hematology/Oncology, vol. 44, Sept. 2021, pp. e896–900. EBSCOhost, https://doi.org/10.1097/mph.0000000000002305.

APA

Bella Beilorai, Gal Dadi, Elad Jacoby, & Amos Toren. (2021). Bortezomib-based Anthracycline-free Induction for Pediatric Relapsed ALL as a Bridge to Immunotherapy. Journal of Pediatric Hematology/Oncology, 44, e896–e900. https://doi.org/10.1097/mph.0000000000002305

Chicago

Bella Beilorai, Gal Dadi, Elad Jacoby, and Amos Toren. 2021. “Bortezomib-Based Anthracycline-Free Induction for Pediatric Relapsed ALL as a Bridge to Immunotherapy.” Journal of Pediatric Hematology/Oncology 44 (September): e896–900. doi:10.1097/mph.0000000000002305.